Crystal Bioscience, Inc.

EMERYVILLE, CA 94608

SBIR Award Summary

Total Number of Awards 5
Total Value of Awards $2.39MM
First Award Date 01/01/10
Most Recent Award Date 08/01/16

Key Personnel

Last Name Name Awards Contact
Harriman Bill Don Harriman 2
Etches Robert Etches 1
Leighton Philip Leighton 2

5 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 08/01/16 - 07/31/17

? DESCRIPTION (provided by applicant): We seek to capitalize on a substantial body of work that has characterized the immune responses of HIV+ individuals with very slow disease progression (LTNP), and HIV- individuals who do not seroconvert despite repeated HIV exposure (ESN). A fraction of people in these groups produce natural anti-CCR5 ant...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-11-096
Budget: 05/01/13 - 04/30/14

DESCRIPTION (provided by applicant): Approximately 25% of the products being developed by the biotechnology industry are antibodies and many of these antibodies are directed to epitopes on human cells and tissues. We are proposing a novel concept for the production of antibodies with therapeutic potential that is based on recent advances in prot...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-11-096
Budget: 05/15/12 - 04/30/13

DESCRIPTION (provided by applicant): Approximately 25% of the products being developed by the biotechnology industry are antibodies and many of these antibodies are directed to epitopes on human cells and tissues. We are proposing a novel concept for the production of antibodies with therapeutic potential that is based on recent advances in prot...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-11-096
Budget: 04/01/12 - 03/31/13

DESCRIPTION (provided by applicant): We seek to capitalize on a substantial body of work has characterized the immune responses of HIV+ individuals with very slow disease progression (LTNP), and HIV- individuals who do not seroconvert despite repeated HIV exposure (ESN). A fraction of people in these groups produce natural anti-CCR5 antibodies t...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-080
Budget: 01/01/10 - 12/31/10

DESCRIPTION (provided by applicant): Approximately 25% of the products being developed by the biotechnology industry are antibodies and many of these antibodies are directed to epitopes on human cells and tissues. We are proposing a novel concept for the production of antibodies with therapeutic potential that is based on recent advances in prot...